Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Luft

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|December 10, 1994
Isolation of pathogenic hantavirus from white-footed mouse (Peromyscus leucopus)J W Song, L J Baek, D C Gajdusek, et al.
JAMA|March 11, 1992
Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infectionB J Luft, C R Steinman, H C Neimark, et al.
Hereditas|January 1, 1997
A population genetic study of Borrelia burgdorferi sensu stricto from eastern Long Island, New York, suggested frequency-dependent selection, gene flow and host adaptationW G Qiu, E M Bosler, J R Campbell, et al.
Infection and Immunity|October 1, 1992
The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigenB J Luft, S Mudri, W Jiang, et al.
Journal of Clinical Microbiology|July 6, 2000
Recombinant chimeric Borrelia proteins for diagnosis of Lyme diseaseM J Gomes-Solecki, J J Dunn, B J Luft, et al.
Clinical and Diagnostic Laboratory Immunology|May 1, 2001
Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virusC Leport, J Franck, G Chene, et al.
The Journal of Infectious Diseases|January 1, 1996
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial GroupC Leport, G Chêne, P Morlat, et al.
The New England Journal of Medicine|September 30, 1993
Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study TeamB J Luft, R Hafner, A H Korzun, et al.
Translational Psychiatry|June 28, 2017
An epigenome-wide DNA methylation study of PTSD and depression in World Trade Center respondersP-F Kuan, M A Waszczuk, R Kotov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1997
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials GroupF Rousseau, S Pueyo, P Morlat, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|December 10, 1994
Isolation of pathogenic hantavirus from white-footed mouse (Peromyscus leucopus)J W Song, L J Baek, D C Gajdusek, et al.
JAMA|March 11, 1992
Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infectionB J Luft, C R Steinman, H C Neimark, et al.
Hereditas|January 1, 1997
A population genetic study of Borrelia burgdorferi sensu stricto from eastern Long Island, New York, suggested frequency-dependent selection, gene flow and host adaptationW G Qiu, E M Bosler, J R Campbell, et al.
Infection and Immunity|October 1, 1992
The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigenB J Luft, S Mudri, W Jiang, et al.
Journal of Clinical Microbiology|July 6, 2000
Recombinant chimeric Borrelia proteins for diagnosis of Lyme diseaseM J Gomes-Solecki, J J Dunn, B J Luft, et al.
Clinical and Diagnostic Laboratory Immunology|May 1, 2001
Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virusC Leport, J Franck, G Chene, et al.
The Journal of Infectious Diseases|January 1, 1996
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial GroupC Leport, G Chêne, P Morlat, et al.
The New England Journal of Medicine|September 30, 1993
Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study TeamB J Luft, R Hafner, A H Korzun, et al.
Translational Psychiatry|June 28, 2017
An epigenome-wide DNA methylation study of PTSD and depression in World Trade Center respondersP-F Kuan, M A Waszczuk, R Kotov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1997
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials GroupF Rousseau, S Pueyo, P Morlat, et al.
Pageof 12